Expected Moves

Oct 27, 2026→Nov 10, 2026

Dec 15, 2026→Dec 29, 2026

Year-end industry capacity checks and contract renegotiations for the specialty chemicals and API segments.

Apr 15, 2027→Apr 29, 2027

Full-year 2026 results and forward capital expenditure guidance.

Jul 20, 2027→Aug 3, 2027

Evaluation of tariff risks on Chinese specialty chemicals and active pharmaceutical ingredients (APIs).